Related Experiment Video
Updated: May 7, 2026

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Parkinson's disease in a dish - Using stem cells as a molecular tool
J L Badger1, O Cordero-Llana, E M Hartfield
1StemBANCC, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK; Molecular Neurodegeneration Group, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK.
Patient-derived induced pluripotent stem cells (iPSCs) offer a powerful way to model Parkinson's disease (PD) in vitro. Studying these cells helps understand disease mechanisms and develop new therapies for this neurodegenerative condition.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder characterized by dopamine neuron loss.
- Both familial and sporadic forms of PD have a significant genetic basis.
- Current treatments do not cure PD, necessitating better disease models for therapeutic development.
Purpose of the Study:
- To review and critique the use of patient-derived induced pluripotent stem cells (iPSCs) for in vitro modeling of Parkinson's disease.
- To explore the potential of iPSCs in advancing Parkinson's disease research.
Main Methods:
- Differentiation of human iPSCs from PD patients into dopaminergic (DA) neurons.
- In vitro analysis of cellular pathways, including calcium regulation and autophagy.
- Examination of how genetic variants in PD influence cellular function.
Main Results:
- Patient-derived iPSC models exhibit key features of Parkinson's disease pathophysiology in vitro.
- Analysis of cellular pathways reveals implications of genetic variants for cellular function.
- iPSC-derived DA neurons provide a platform for studying PD mechanisms.
Conclusions:
- Patient-derived iPSCs are a valuable tool for in vitro modeling of Parkinson's disease.
- iPSC technology holds significant promise for future PD research and therapeutic discovery.
- Understanding cellular pathway dysregulation in iPSC models can inform treatment strategies.
More Related Videos
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
09:34Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
Published on: August 6, 2020
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells